MX2015017555A - Metodos y composiciones para aumentar la movilizacion de las celulas madre. - Google Patents

Metodos y composiciones para aumentar la movilizacion de las celulas madre.

Info

Publication number
MX2015017555A
MX2015017555A MX2015017555A MX2015017555A MX2015017555A MX 2015017555 A MX2015017555 A MX 2015017555A MX 2015017555 A MX2015017555 A MX 2015017555A MX 2015017555 A MX2015017555 A MX 2015017555A MX 2015017555 A MX2015017555 A MX 2015017555A
Authority
MX
Mexico
Prior art keywords
stem cells
stem cell
cell mobilization
compositions
methods
Prior art date
Application number
MX2015017555A
Other languages
English (en)
Inventor
Christian Drapeau
S Jensen Gitte
Original Assignee
Stemtech International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemtech International Inc filed Critical Stemtech International Inc
Publication of MX2015017555A publication Critical patent/MX2015017555A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/066—Clavicipitaceae
    • A61K36/068—Cordyceps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)

Abstract

La presente invención proporciona un método para utilizar agentes de movilización para aumentar la movilización de células madre en un sujeto, que incluye las células madre hematopoyéticas (HSC) y las células madre de médula ósea (BMSC). En una modalidad, se utiliza una composición mezclada de frutas, hongos, microorganismos, fluidos maternales y extractos de estos para promover el tráfico de células madre, lo que da como resultado la migración de las células madre a sitios específicos de mantenimiento y la reparación dentro de tejidos y/u órganos. La circulación aumentada de HSC y/o BMSC y la migración hacia sitios de mantenimiento y los mecanismos de regeneración natural en el cuerpo. Se proporciona además un régimen de dosificación para la administración de fucoidan y un método para aumentar la liberación y circulación de las células madre.
MX2015017555A 2013-06-19 2014-06-19 Metodos y composiciones para aumentar la movilizacion de las celulas madre. MX2015017555A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361837045P 2013-06-19 2013-06-19
PCT/US2014/043237 WO2014205250A1 (en) 2013-06-19 2014-06-19 Methods and compositions for enhancing stem cell mobilization

Publications (1)

Publication Number Publication Date
MX2015017555A true MX2015017555A (es) 2016-04-26

Family

ID=52105299

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015017555A MX2015017555A (es) 2013-06-19 2014-06-19 Metodos y composiciones para aumentar la movilizacion de las celulas madre.

Country Status (13)

Country Link
US (1) US20160136225A1 (es)
EP (1) EP3010482A4 (es)
JP (1) JP2016522265A (es)
KR (1) KR20160021182A (es)
AU (1) AU2014281338A1 (es)
BR (1) BR112015031813A2 (es)
CA (1) CA2912185A1 (es)
HK (1) HK1223826A1 (es)
MX (1) MX2015017555A (es)
PH (1) PH12015502827A1 (es)
RU (1) RU2016101222A (es)
SG (1) SG11201509437XA (es)
WO (1) WO2014205250A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10159705B2 (en) 2010-06-28 2018-12-25 Stemtech IP Holdings, LLC Methods and compositions for enhancing stem cell mobilization
WO2013074801A1 (en) 2011-11-18 2013-05-23 Stemtech International, Inc. Use of foti to enhance stem cell mobilization and proliferation
CN105852125A (zh) * 2016-04-27 2016-08-17 深圳爱生再生医学科技有限公司 芦荟干细胞冻干粉及其制备方法和应用
US20180021326A1 (en) * 2016-07-23 2018-01-25 Paul Edward Stamets Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin
JP7076709B2 (ja) * 2016-08-18 2022-05-30 北海道公立大学法人 札幌医科大学 間葉系幹細胞活性化剤
CN110192623A (zh) * 2019-07-05 2019-09-03 福建冠丰生物科技有限公司 一种海参牡蛎复合型营养低聚肽粉及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1282952B1 (it) * 1996-01-24 1998-04-02 Silvie Limited Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento della costipazione
CA2435196A1 (fr) * 2003-07-21 2005-01-21 Thi Thanh Nguyen Methode de traitement radical et etiologique contre les rides et vieillissement precoces
MA29706B1 (fr) * 2007-02-14 2008-09-01 Philippe Alleon Complement alimentaire comprenant de la spiruline et un produit a base de plante du genre aloe, et son utilisation cosmetique
US10159705B2 (en) * 2010-06-28 2018-12-25 Stemtech IP Holdings, LLC Methods and compositions for enhancing stem cell mobilization
BR112014002626A2 (pt) * 2011-08-05 2017-04-04 Stemtech Int Inc composições de cuidados da pele que contêm combinações de ingredientes naturais
WO2013074801A1 (en) * 2011-11-18 2013-05-23 Stemtech International, Inc. Use of foti to enhance stem cell mobilization and proliferation

Also Published As

Publication number Publication date
PH12015502827A1 (en) 2016-03-21
WO2014205250A1 (en) 2014-12-24
EP3010482A4 (en) 2016-11-02
KR20160021182A (ko) 2016-02-24
US20160136225A1 (en) 2016-05-19
RU2016101222A (ru) 2017-07-24
CA2912185A1 (en) 2014-12-24
EP3010482A1 (en) 2016-04-27
SG11201509437XA (en) 2015-12-30
BR112015031813A2 (pt) 2017-07-25
AU2014281338A1 (en) 2015-11-26
JP2016522265A (ja) 2016-07-28
HK1223826A1 (zh) 2017-08-11

Similar Documents

Publication Publication Date Title
PH12015502827A1 (en) Methods and compositions for enhancing stem cell mobilization
MY170013A (en) Methods and compositions for enhancing stem cell mobilization
EP4249916A3 (en) Compositions and methods for non-myeloablative conditioning
HK1219293A1 (zh) 產生軟骨細胞譜系細胞和/或類軟骨組織的方法和組合物
MX2019003616A (es) Celulas beta derivadas de celulas madre (sc-beta) y composiciones y metodos para generarlas.
BR112015006426A2 (pt) composições nutricionais que incluem beta-hidróxi-beta-metilbutirato de cálcio, proteína e baixos níveis de eletrólitos
WO2013070881A8 (en) Method for elimination of space through tissue approximation
PH12014502711A1 (en) Compositions and methods for enhancing mobilization and proliferation of blastomere-like stem cells
GT201400043A (es) Imidazopiridazinas sustituidas con amino
EA201490995A1 (ru) Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток
PE20150223A1 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos
EP2603227A4 (en) IMPROVED HEMATOPOETIC TRIBE AND PRECURSOR CELL THERAPY
BR112014031874A2 (pt) método para preparar células-tronco em concentração elevada
MX2013006073A (es) Dispositivos de recogida de sangre que contienen un agente estabilizador de sangre.
BR112015032570A2 (pt) lipoenchimento com células-tronco derivadas de tecido adiposo expandidas ex vivo para preenchimento de mama estético ou para preenchimento e/ou rejuvenescimento facial
MX2016004556A (es) Composicion de hueso comprimido y metodo para usar la misma.
BR112013006938A2 (pt) kits, componentes e métodos para reconstrução de tecido
MX2016004285A (es) Tratamiento de tumor por combinacion con minicelulas dirigidas a ligando, biespecificas, cargadas con farmacos e interferon-gamma.
NZ703345A (en) Compositions and methods for reducing frequency and/or severity of headache
MX2016005824A (es) Metodo de cultivo celular.
BR112019017393A2 (pt) formulações de evolocumab de baixa viscosidade, alta concentração e métodos para produzir as mesmas
MX2020004811A (es) Métodos y composiciones de reconstrucción no mieloablativa de médula ósea.
MX2021016114A (es) Formulaciones para estabilizar la humedad en alimentos musculares.
TR201811308T4 (tr) Kanser kok hücrelerini azaltan anti-emp2 tedavisi.
PH12017500018A1 (en) Myo-inositol and probiotics, and their use